Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb;83(2):130-132.
doi: 10.1053/j.ajkd.2023.10.003. Epub 2023 Dec 9.

Combined Angiotensin Inhibition for CKD: The Truth Is Rarely Pure and Never Simple

Affiliations
Editorial

Combined Angiotensin Inhibition for CKD: The Truth Is Rarely Pure and Never Simple

Anand Srivastava et al. Am J Kidney Dis. 2024 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Xie X, Liu Y, Perkovic V, et al. Renin-angiotensin system inhibitors and kidney and cardiovascular outcomes in patients with CKD: a Bayesian network meta-analysis of randomized clinical trials. Am J Kidney Dis. 2016;67(5):728–741. doi:10.1053/j.ajkd.2015.10.011 - DOI - PubMed
    1. Cheung AK, Chang TI, Cushman WC, et al. KDIGO 2021 Clinical Practice Guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3):S1–S87. doi:10.1016/j.kint.2020.11.003 - DOI - PubMed
    1. Levin A, Stevens PE, Bilous RW, et al. Kidney disease: Improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150. doi:10.1038/kisup.2012.73 - DOI
    1. Ménard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats. Circulation. 1997;96(9):3072–3078. doi:10.1161/01.CIR.96.9.3072 - DOI - PubMed
    1. Fossa AA, Depasquale MJ, Ringer LJ, Winslow RL. Synergistic effect on reduction in blood pressure with coadministration of a renin inhibitor or an angiotensin-converting enzyme inhibitor with an angiotensin II receptor antagonist. Drug Dev Res. 1994;33(4):422–428. doi:10.1002/ddr.430330405 - DOI

MeSH terms

Substances

LinkOut - more resources